Accumulating research has shown that CERK and its metabolite C1P play complex regulatory roles in several kinds of tumors, such as leukemia, breast cancer, lung cancer, neuroblastoma, pancreatic cancer, and prostate cancer. This evidence concerns the gene CERK and breast carcinoma.